PER 2.86% 7.2¢ percheron therapeutics limited

ANP holders were dreaming of a Trading Halt and an announcement....

  1. 11,703 Posts.
    lightbulb Created with Sketch. 1077
    ANP holders were dreaming of a Trading Halt and an announcement. Its happened for ATL1103. And yet holders are nervous?? This announcement was expected in Q1 2012.

    Bad results SP will go down good result SP will go up. A few days leading to fridays trade we had serious pressure on the SP, with the SP hitting 2.5c. So quite a few would have exited before fridays bullish hammer reversal day. With buyers in full control that day.


    Read ANPs announcement on the 09/06/2011 for what to potentially expect.

    9 June 2011
    ANP Receives Funding to Complete Additional Key Studies on ATL1103
    ? Receives additional funding through placement to Australian based boutique investment fund
    ? Funding allows ANP to complete its ATL1103 Phase I study including the multiple dose stage of
    the trial and to conduct its proposed ATL1103 cancer experimental program
    ? Cancer experimental program to be conducted in parallel with planned Phase I clinical trial due
    to commence Q3 2011
    ? Both stages of the Phase I trial (single ascending dose and multiple dose) as well as cancer
    program expected to be completed in Q1 2012
    ? ANP development focus on ATL1103 with negotiations advancing for the development and
    funding of pipeline project by potential partner
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $64.91M
Open High Low Value Volume
7.4¢ 7.4¢ 7.0¢ $44.32K 616.8K

Buyers (Bids)

No. Vol. Price($)
1 4250 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 49809 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.